0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Gene Testing Service Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-1E16871
Home | Market Reports | Health| Health Conditions| Cancer
Cancer Gene Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Cancer Gene Testing Service Market Research Report 2025

Code: QYRE-Auto-1E16871
Report
May 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cancer Gene Testing Service Market

The global market for Cancer Gene Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cancer Gene Testing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Gene Testing Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Gene Testing Service in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Gene Testing Service include Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Twist Bioscience, Sophia Genetics, Fulgent Genetic, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Gene Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Gene Testing Service.
The Cancer Gene Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Gene Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Gene Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Gene Testing Service Market Report

Report Metric Details
Report Name Cancer Gene Testing Service Market
Segment by Type
  • Breast Cancer Risk Genetic Testing
  • Stomach Cancer Risk Gene Testing
  • Rectal Cancer Risk Genetic Testing
  • Others
Segment by Application
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Twist Bioscience, Sophia Genetics, Fulgent Genetic, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Gene Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Gene Testing Service Market report?

Ans: The main players in the Cancer Gene Testing Service Market are Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Twist Bioscience, Sophia Genetics, Fulgent Genetic, Inc.

What are the Application segmentation covered in the Cancer Gene Testing Service Market report?

Ans: The Applications covered in the Cancer Gene Testing Service Market report are Hospital, Clinic

What are the Type segmentation covered in the Cancer Gene Testing Service Market report?

Ans: The Types covered in the Cancer Gene Testing Service Market report are Breast Cancer Risk Genetic Testing, Stomach Cancer Risk Gene Testing, Rectal Cancer Risk Genetic Testing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Testing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Breast Cancer Risk Genetic Testing
1.2.3 Stomach Cancer Risk Gene Testing
1.2.4 Rectal Cancer Risk Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Gene Testing Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Testing Service Market Perspective (2020-2031)
2.2 Global Cancer Gene Testing Service Growth Trends by Region
2.2.1 Global Cancer Gene Testing Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Gene Testing Service Historic Market Size by Region (2020-2025)
2.2.3 Cancer Gene Testing Service Forecasted Market Size by Region (2026-2031)
2.3 Cancer Gene Testing Service Market Dynamics
2.3.1 Cancer Gene Testing Service Industry Trends
2.3.2 Cancer Gene Testing Service Market Drivers
2.3.3 Cancer Gene Testing Service Market Challenges
2.3.4 Cancer Gene Testing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Gene Testing Service Players by Revenue
3.1.1 Global Top Cancer Gene Testing Service Players by Revenue (2020-2025)
3.1.2 Global Cancer Gene Testing Service Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Gene Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Gene Testing Service Revenue
3.4 Global Cancer Gene Testing Service Market Concentration Ratio
3.4.1 Global Cancer Gene Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Testing Service Revenue in 2024
3.5 Global Key Players of Cancer Gene Testing Service Head office and Area Served
3.6 Global Key Players of Cancer Gene Testing Service, Product and Application
3.7 Global Key Players of Cancer Gene Testing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Gene Testing Service Breakdown Data by Type
4.1 Global Cancer Gene Testing Service Historic Market Size by Type (2020-2025)
4.2 Global Cancer Gene Testing Service Forecasted Market Size by Type (2026-2031)
5 Cancer Gene Testing Service Breakdown Data by Application
5.1 Global Cancer Gene Testing Service Historic Market Size by Application (2020-2025)
5.2 Global Cancer Gene Testing Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Gene Testing Service Market Size (2020-2031)
6.2 North America Cancer Gene Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Gene Testing Service Market Size by Country (2020-2025)
6.4 North America Cancer Gene Testing Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Gene Testing Service Market Size (2020-2031)
7.2 Europe Cancer Gene Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Gene Testing Service Market Size by Country (2020-2025)
7.4 Europe Cancer Gene Testing Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Gene Testing Service Market Size (2020-2031)
8.2 Asia-Pacific Cancer Gene Testing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Gene Testing Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Gene Testing Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Gene Testing Service Market Size (2020-2031)
9.2 Latin America Cancer Gene Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Gene Testing Service Market Size by Country (2020-2025)
9.4 Latin America Cancer Gene Testing Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Gene Testing Service Market Size (2020-2031)
10.2 Middle East & Africa Cancer Gene Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Gene Testing Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Gene Testing Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Natera, Inc.
11.1.1 Natera, Inc. Company Details
11.1.2 Natera, Inc. Business Overview
11.1.3 Natera, Inc. Cancer Gene Testing Service Introduction
11.1.4 Natera, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025)
11.1.5 Natera, Inc. Recent Development
11.2 Laboratory Corporation of America Holdings
11.2.1 Laboratory Corporation of America Holdings Company Details
11.2.2 Laboratory Corporation of America Holdings Business Overview
11.2.3 Laboratory Corporation of America Holdings Cancer Gene Testing Service Introduction
11.2.4 Laboratory Corporation of America Holdings Revenue in Cancer Gene Testing Service Business (2020-2025)
11.2.5 Laboratory Corporation of America Holdings Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Gene Testing Service Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Quest Diagnostics Incorporated
11.4.1 Quest Diagnostics Incorporated Company Details
11.4.2 Quest Diagnostics Incorporated Business Overview
11.4.3 Quest Diagnostics Incorporated Cancer Gene Testing Service Introduction
11.4.4 Quest Diagnostics Incorporated Revenue in Cancer Gene Testing Service Business (2020-2025)
11.4.5 Quest Diagnostics Incorporated Recent Development
11.5 CooperSurgical, Inc.
11.5.1 CooperSurgical, Inc. Company Details
11.5.2 CooperSurgical, Inc. Business Overview
11.5.3 CooperSurgical, Inc. Cancer Gene Testing Service Introduction
11.5.4 CooperSurgical, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025)
11.5.5 CooperSurgical, Inc. Recent Development
11.6 Agilent Technologies, Inc.
11.6.1 Agilent Technologies, Inc. Company Details
11.6.2 Agilent Technologies, Inc. Business Overview
11.6.3 Agilent Technologies, Inc. Cancer Gene Testing Service Introduction
11.6.4 Agilent Technologies, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025)
11.6.5 Agilent Technologies, Inc. Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Details
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Twist Bioscience
11.8.1 Twist Bioscience Company Details
11.8.2 Twist Bioscience Business Overview
11.8.3 Twist Bioscience Cancer Gene Testing Service Introduction
11.8.4 Twist Bioscience Revenue in Cancer Gene Testing Service Business (2020-2025)
11.8.5 Twist Bioscience Recent Development
11.9 Sophia Genetics
11.9.1 Sophia Genetics Company Details
11.9.2 Sophia Genetics Business Overview
11.9.3 Sophia Genetics Cancer Gene Testing Service Introduction
11.9.4 Sophia Genetics Revenue in Cancer Gene Testing Service Business (2020-2025)
11.9.5 Sophia Genetics Recent Development
11.10 Fulgent Genetic, Inc.
11.10.1 Fulgent Genetic, Inc. Company Details
11.10.2 Fulgent Genetic, Inc. Business Overview
11.10.3 Fulgent Genetic, Inc. Cancer Gene Testing Service Introduction
11.10.4 Fulgent Genetic, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025)
11.10.5 Fulgent Genetic, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cancer Gene Testing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Breast Cancer Risk Genetic Testing
 Table 3. Key Players of Stomach Cancer Risk Gene Testing
 Table 4. Key Players of Rectal Cancer Risk Genetic Testing
 Table 5. Key Players of Others
 Table 6. Global Cancer Gene Testing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cancer Gene Testing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Cancer Gene Testing Service Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Cancer Gene Testing Service Market Share by Region (2020-2025)
 Table 10. Global Cancer Gene Testing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Cancer Gene Testing Service Market Share by Region (2026-2031)
 Table 12. Cancer Gene Testing Service Market Trends
 Table 13. Cancer Gene Testing Service Market Drivers
 Table 14. Cancer Gene Testing Service Market Challenges
 Table 15. Cancer Gene Testing Service Market Restraints
 Table 16. Global Cancer Gene Testing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Cancer Gene Testing Service Market Share by Players (2020-2025)
 Table 18. Global Top Cancer Gene Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Testing Service as of 2024)
 Table 19. Ranking of Global Top Cancer Gene Testing Service Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Cancer Gene Testing Service Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Cancer Gene Testing Service, Headquarters and Area Served
 Table 22. Global Key Players of Cancer Gene Testing Service, Product and Application
 Table 23. Global Key Players of Cancer Gene Testing Service, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Cancer Gene Testing Service Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Cancer Gene Testing Service Revenue Market Share by Type (2020-2025)
 Table 27. Global Cancer Gene Testing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Cancer Gene Testing Service Revenue Market Share by Type (2026-2031)
 Table 29. Global Cancer Gene Testing Service Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Cancer Gene Testing Service Revenue Market Share by Application (2020-2025)
 Table 31. Global Cancer Gene Testing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Cancer Gene Testing Service Revenue Market Share by Application (2026-2031)
 Table 33. North America Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Cancer Gene Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Cancer Gene Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Cancer Gene Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Cancer Gene Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Cancer Gene Testing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Cancer Gene Testing Service Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Cancer Gene Testing Service Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Cancer Gene Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cancer Gene Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Cancer Gene Testing Service Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Cancer Gene Testing Service Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Natera, Inc. Company Details
 Table 49. Natera, Inc. Business Overview
 Table 50. Natera, Inc. Cancer Gene Testing Service Product
 Table 51. Natera, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 52. Natera, Inc. Recent Development
 Table 53. Laboratory Corporation of America Holdings Company Details
 Table 54. Laboratory Corporation of America Holdings Business Overview
 Table 55. Laboratory Corporation of America Holdings Cancer Gene Testing Service Product
 Table 56. Laboratory Corporation of America Holdings Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 57. Laboratory Corporation of America Holdings Recent Development
 Table 58. F. Hoffmann-La Roche Ltd Company Details
 Table 59. F. Hoffmann-La Roche Ltd Business Overview
 Table 60. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Product
 Table 61. F. Hoffmann-La Roche Ltd Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 62. F. Hoffmann-La Roche Ltd Recent Development
 Table 63. Quest Diagnostics Incorporated Company Details
 Table 64. Quest Diagnostics Incorporated Business Overview
 Table 65. Quest Diagnostics Incorporated Cancer Gene Testing Service Product
 Table 66. Quest Diagnostics Incorporated Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 67. Quest Diagnostics Incorporated Recent Development
 Table 68. CooperSurgical, Inc. Company Details
 Table 69. CooperSurgical, Inc. Business Overview
 Table 70. CooperSurgical, Inc. Cancer Gene Testing Service Product
 Table 71. CooperSurgical, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 72. CooperSurgical, Inc. Recent Development
 Table 73. Agilent Technologies, Inc. Company Details
 Table 74. Agilent Technologies, Inc. Business Overview
 Table 75. Agilent Technologies, Inc. Cancer Gene Testing Service Product
 Table 76. Agilent Technologies, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 77. Agilent Technologies, Inc. Recent Development
 Table 78. Thermo Fisher Scientific, Inc. Company Details
 Table 79. Thermo Fisher Scientific, Inc. Business Overview
 Table 80. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Product
 Table 81. Thermo Fisher Scientific, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 82. Thermo Fisher Scientific, Inc. Recent Development
 Table 83. Twist Bioscience Company Details
 Table 84. Twist Bioscience Business Overview
 Table 85. Twist Bioscience Cancer Gene Testing Service Product
 Table 86. Twist Bioscience Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 87. Twist Bioscience Recent Development
 Table 88. Sophia Genetics Company Details
 Table 89. Sophia Genetics Business Overview
 Table 90. Sophia Genetics Cancer Gene Testing Service Product
 Table 91. Sophia Genetics Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 92. Sophia Genetics Recent Development
 Table 93. Fulgent Genetic, Inc. Company Details
 Table 94. Fulgent Genetic, Inc. Business Overview
 Table 95. Fulgent Genetic, Inc. Cancer Gene Testing Service Product
 Table 96. Fulgent Genetic, Inc. Revenue in Cancer Gene Testing Service Business (2020-2025) & (US$ Million)
 Table 97. Fulgent Genetic, Inc. Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Cancer Gene Testing Service Picture
 Figure 2. Global Cancer Gene Testing Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Gene Testing Service Market Share by Type: 2024 VS 2031
 Figure 4. Breast Cancer Risk Genetic Testing Features
 Figure 5. Stomach Cancer Risk Gene Testing Features
 Figure 6. Rectal Cancer Risk Genetic Testing Features
 Figure 7. Others Features
 Figure 8. Global Cancer Gene Testing Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Cancer Gene Testing Service Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Cancer Gene Testing Service Report Years Considered
 Figure 13. Global Cancer Gene Testing Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cancer Gene Testing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cancer Gene Testing Service Market Share by Region: 2024 VS 2031
 Figure 16. Global Cancer Gene Testing Service Market Share by Players in 2024
 Figure 17. Global Top Cancer Gene Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Testing Service as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cancer Gene Testing Service Revenue in 2024
 Figure 19. North America Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cancer Gene Testing Service Market Share by Country (2020-2031)
 Figure 21. United States Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cancer Gene Testing Service Market Share by Country (2020-2031)
 Figure 25. Germany Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cancer Gene Testing Service Market Share by Region (2020-2031)
 Figure 33. China Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cancer Gene Testing Service Market Share by Country (2020-2031)
 Figure 41. Mexico Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cancer Gene Testing Service Market Share by Country (2020-2031)
 Figure 45. Turkey Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cancer Gene Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Natera, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 49. Laboratory Corporation of America Holdings Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 51. Quest Diagnostics Incorporated Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 52. CooperSurgical, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 54. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 55. Twist Bioscience Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 56. Sophia Genetics Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 57. Fulgent Genetic, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart